FDA Seeks Public Comment on Proposed Collection of Information for Protection of Human Subjects

Summary

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information that has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. The FDA is seeking to obtain public feedback on the proposed collection of information, which relates to the protection of human subjects and informed consent, as well as the use of institutional review boards.